Blood-Based Minimal Residual Disease in Advanced Epithelial Ovarian Cancer After 1st Line Therapy
Clinical trial NCT07670962 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07670962
- Sponsor
- Asan Medical Center
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-06-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.